Skip to content

Haemonetics HAE Ratios & Valuation

Q4 '26Q3 '26Q2 '26Q1 '26Q4 '25
Profitability
Gross margin59%+4.0pp59.4%+6.1pp58.3%+5.6pp56.9%+4.5pp55%+2.2pp
Free cash flow margin19.5%+9.1pp23.4%+16.2pp19.3%14.1%10.5%
Efficiency
Asset turnover0.6×0.0×0.5×-0.1×0.5×-0.1×0.5×-0.1×0.6×0.0×
Inventory turnover1.6×-0.2×1.6×-0.4×1.5×-0.4×1.6×-0.3×1.8×-0.3×
Liquidity
Current ratio+1.3×1.7×-2.2×1.6×-1.8×1.7×-2.0×1.6×-0.9×
Quick ratio1.9×+0.9×1.2×-1.4×-1.1×-1.3×-0.5×
Cash ratio0.9×+0.3×0.7×-0.6×0.5×-0.6×0.6×-0.8×0.5×-0.1×
Leverage
Debt-to-equity1.6×0.0×1.3×0.0×1.4×0.0×1.4×0.0×1.6×+0.7×
Debt-to-assets0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×0.5×+0.1×
Per Share
Book value per share$16.82+3.9%$19.40+8.3%$17.82+3.9%$18.25+3.9%$16.18-13.4%
Valuation
Market capitalization$2.62B-18.0%$3.75B-4.3%$2.35B-42.9%$3.51B-16.7%$3.19B-26.3%
Enterprise value$3.65B-12.5%$4.61B-4.4%$3.28B-35.0%$4.44B-12.8%$4.17B-17.1%
Price / sales-0.4×2.8×0.0×1.8×-1.3×2.6×-0.6×2.3×-1.0×
Price / book3.3×-0.6×4.1×-0.2×2.8×-1.9×-0.7×3.9×-0.6×
EV / sales2.7×-0.3×3.5×0.0×2.5×-1.2×3.3×-0.5×3.1×-0.8×
Free cash flow yield9.9%+5.5pp8.2%+5.7pp10.9%5.4%4.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Haemonetics's profit margins?
Haemonetics (HAE) runs a 59.0% gross margin and a 19.0% operating margin, with a 13.3% net margin.
Where do Haemonetics's ratios come from?
Every ratio is computed from Haemonetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.